# Outlook Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/outlook-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 28 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T04:46:51.907669+00:00 | | Last reviewed | 2026-10-16T04:46:51.907669+00:00 | ## Identity - Legal name: Outlook Therapeutics, Inc. - Display name: Outlook Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T08:23:44.391389+00:00 | | Completeness | 0.409 | | Record Quality | 0.84 | | Directors | 10 | | Committees | 6 | | Governance events | 20 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Amy (Yin-Zhen) Huang: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:5 - Faisal G. Sukhtian: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Nominating and Governance (chair); Nominating and Governance · Chair (member). claim_id=alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:6 - Gerd Auffarth: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:7 - Julia A. Haller: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:8 - Julian Gangolli: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member). claim_id=alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:9 - Kurt J. Hilzinger: Director. Status: current. Independent: true. Since: 2015-01-01. Committees: Audit (chair); Audit · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:10 - Lawrence A. Kenyon: Director. Status: current. Independent: false. Since: 2015-01-01. claim_id=alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:11 - Ralph H. Randy Thurman: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Audit (member); Audit; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:12 - Robert C. Jahr: Director. Status: current. Independent: false. Since: 2025-01-01. claim_id=alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:13 - Yezan Haddadin: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:14 ## Committees - Audit (audit). Chair: Kurt J. Hilzinger. Members: Kurt J. Hilzinger (chair, current); Julian Gangolli (member, current); Ralph H. Randy Thurman (member, current). committee_id=alpha:committee:outlook-therapeutics-inc:audit - Audit · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Kurt J. Hilzinger (member, current). committee_id=alpha:committee:outlook-therapeutics-inc:audit-chair-compensation - Audit; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Ralph H. Randy Thurman (member, current). committee_id=alpha:committee:outlook-therapeutics-inc:audit-compensation-chair - Compensation (compensation). Chair: Ralph H. Randy Thurman. Members: Ralph H. Randy Thurman (chair, current); Kurt J. Hilzinger (member, current); Yezan Haddadin (member, current). committee_id=alpha:committee:outlook-therapeutics-inc:compensation - Nominating and Governance (nominating_governance). Chair: Faisal G. Sukhtian. Members: Faisal G. Sukhtian (chair, current); Gerd Auffarth (member, current); Julia A. Haller (member, current). committee_id=alpha:committee:outlook-therapeutics-inc:nominating-and-governance - Nominating and Governance · Chair (nominating_governance). Chair: NOT_PUBLISHED. Members: Faisal G. Sukhtian (member, current). committee_id=alpha:committee:outlook-therapeutics-inc:nominating-and-governance-chair ## Executive leadership - Lawrence A. Kenyon: Executive Vice President, Chief Financial Officer, Treasurer, Corporate Secretary and Director [CFO]. Status: current. claim_id=alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:15 - Robert C. Jahr: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:16 ## Governance events - CFO_CHANGED: Lawrence A. Kenyon executive of Outlook Therapeutics, Inc., effective 2026-01-26. Effective: 2026-01-26. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:1ccqyte11edkle - CEO_CHANGED: Robert C. Jahr executive of Outlook Therapeutics, Inc., effective 2026-01-26. Effective: 2026-01-26. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:10c23gnea355v - DIRECTOR_APPOINTED: Robert C. Jahr seat on Outlook Therapeutics, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:16kb3z71o2f7uj - DIRECTOR_APPOINTED: Julia A. Haller seat on Outlook Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:aamhuu1x1c5mm - DIRECTOR_APPOINTED: Amy (Yin-Zhen) Huang seat on Outlook Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:1h97dbv8ty9fx - DIRECTOR_APPOINTED: Gerd Auffarth seat on Outlook Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:cqj1xl11nx4n3 - DIRECTOR_APPOINTED: Julian Gangolli seat on Outlook Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:6d3intcsw8zp - COMMITTEE_MEMBER_ADDED: Julian Gangolli member of Audit, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:1nq6puc1t4v7qu - COMMITTEE_MEMBER_ADDED: Gerd Auffarth member of Nominating and Governance, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:o5ygsv1biydk1 - DIRECTOR_APPOINTED: Ralph H. Randy Thurman seat on Outlook Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:1wk8z1u11j54i8 - COMMITTEE_CREATED: Audit; Compensation · Chair committee of Outlook Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:1wfcu6s1v2znh8 - COMMITTEE_MEMBER_ADDED: Ralph H. Randy Thurman member of Audit; Compensation · Chair, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:vibnfo1ferfqc - DIRECTOR_APPOINTED: Faisal G. Sukhtian seat on Outlook Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:1h2hxqg16m1nsy - DIRECTOR_APPOINTED: Yezan Haddadin seat on Outlook Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:xlb47n9mo99l - COMMITTEE_CREATED: Nominating and Governance · Chair committee of Outlook Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:lf9re01skjxui - COMMITTEE_MEMBER_ADDED: Faisal G. Sukhtian member of Nominating and Governance · Chair, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:s8gej1rsej1d - DIRECTOR_APPOINTED: Kurt J. Hilzinger seat on Outlook Therapeutics, Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:1oztmih1k8r48n - DIRECTOR_APPOINTED: Lawrence A. Kenyon seat on Outlook Therapeutics, Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:ol24yazj5ciq - COMMITTEE_CREATED: Audit · Chair; Compensation committee of Outlook Therapeutics, Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:sv4bb14pkt7v - COMMITTEE_MEMBER_ADDED: Kurt J. Hilzinger member of Audit · Chair; Compensation, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T04:46:51.907669+00:00. event_id=alpha:event:transition:4mq3cv1hieeo3 ## Scoped resources - `alpha://company/outlook-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record - `alpha://company/outlook-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=identity - `alpha://company/outlook-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/outlook-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=board - `alpha://company/outlook-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=committees - `alpha://company/outlook-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=leadership - `alpha://company/outlook-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=ownership - `alpha://company/outlook-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=financials - `alpha://company/outlook-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/outlook-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=compensation - `alpha://company/outlook-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=governance - `alpha://company/outlook-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/outlook-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=audit - `alpha://company/outlook-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=legal - `alpha://company/outlook-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=risk - `alpha://company/outlook-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=cyber - `alpha://company/outlook-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/outlook-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=agents - `alpha://company/outlook-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/outlook-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=events - `alpha://company/outlook-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=relationships - `alpha://company/outlook-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=assessments - `alpha://company/outlook-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:kurt-j-hilzinger","name":"Kurt J. Hilzinger"},"source_id":"board_seats"}` - Claim alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:julian-gangolli","name":"Julian Gangolli"},"source_id":"board_seats"}` - Claim alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:ralph-h-randy-thurman","name":"Ralph H. Randy Thurman"},"source_id":"board_seats"}` - Claim alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:ralph-h-randy-thurman","name":"Ralph H. Randy Thurman"},"source_id":"board_seats"}` - Claim alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:kurt-j-hilzinger","name":"Kurt J. Hilzinger"},"source_id":"board_seats"}` - Claim alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:yezan-haddadin","name":"Yezan Haddadin"},"source_id":"board_seats"}` - Claim alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:faisal-g-sukhtian","name":"Faisal G. Sukhtian"},"source_id":"board_seats"}` - Claim alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:gerd-auffarth","name":"Gerd Auffarth"},"source_id":"board_seats"}` - Claim alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:julia-a-haller","name":"Julia A. Haller"},"source_id":"board_seats"}` ## Leadership - Amy (Yin-Zhen) Huang: Director. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:5. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850. - Faisal G. Sukhtian: Director, Nominating and Governance · Chair. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:6. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850. - Gerd Auffarth: Director, Nominating and Governance. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850. - Julia A. Haller: Director, Nominating and Governance. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:8. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850. - Julian Gangolli: Director, Audit. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:9. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850. - Kurt J. Hilzinger: Director, Audit · Chair; Compensation. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:10. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850. - Lawrence A. Kenyon: Director. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:11. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850. - Ralph H. Randy Thurman: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:12. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850. - Robert C. Jahr: Director. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:13. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850. - Yezan Haddadin: Director, Compensation. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:14. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850. - Lawrence A. Kenyon: Executive Vice President, Chief Financial Officer, Treasurer, Corporate Secretary and Director. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:15. Valid from: 2026-01-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ccd41587a8199286a9dd54828a62a4c6325cccba47a60a1ccb1d5477bf9de125. - Robert C. Jahr: President and Chief Executive Officer. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:16. Valid from: 2026-01-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bb03942565b714b361a19daadb85146fd4a7b30e949e41461a14c8db584a6057. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Kurt J. Hilzinger; Members Kurt J. Hilzinger (Chair); Julian Gangolli; Ralph H. Randy Thurman. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc. - Compensation: Chair Ralph H. Randy Thurman; Members Ralph H. Randy Thurman (Chair); Kurt J. Hilzinger; Yezan Haddadin. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc. - Nominating and Governance: Chair Faisal G. Sukhtian; Members Faisal G. Sukhtian (Chair); Gerd Auffarth; Julia A. Haller. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Outlook Therapeutics, Inc.. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:723274ed369cb9734f96e5a2bbc34ea89b0d1cdf898a1333e392593a29bd160a. ## Entity Status - Public listing published. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:723274ed369cb9734f96e5a2bbc34ea89b0d1cdf898a1333e392593a29bd160a. ## Published Fact - US. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:723274ed369cb9734f96e5a2bbc34ea89b0d1cdf898a1333e392593a29bd160a. ## Committee Appointment - Kurt J. Hilzinger: chair, Audit. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc. - Julian Gangolli: member, Audit. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc. - Ralph H. Randy Thurman: member, Audit. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc. - Ralph H. Randy Thurman: chair, Compensation. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc. - Kurt J. Hilzinger: member, Compensation. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc. - Yezan Haddadin: member, Compensation. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc. - Faisal G. Sukhtian: chair, Nominating and Governance. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc. - Gerd Auffarth: member, Nominating and Governance. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc. - Julia A. Haller: member, Nominating and Governance. Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc. ## Security Listing - OTLK (NASDAQ). Claim: alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:security_listing:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:723274ed369cb9734f96e5a2bbc34ea89b0d1cdf898a1333e392593a29bd160a. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:723274ed369cb9734f96e5a2bbc34ea89b0d1cdf898a1333e392593a29bd160a: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/outlook-therapeutics-inc). - alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850: [Outlook Therapeutics, Inc. DEF 14A 2026-01-26](https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm). - alpha:projection-evidence:document:ccd41587a8199286a9dd54828a62a4c6325cccba47a60a1ccb1d5477bf9de125: [OTLK DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm). - alpha:projection-evidence:document:bb03942565b714b361a19daadb85146fd4a7b30e949e41461a14c8db584a6057: [OTLK DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm). - alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc: [Audit](https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/outlook-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/outlook-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/outlook-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T08:23:44.202347+00:00; recorded 2026-10-16T08:23:44.202347+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.